HARTFORD INSURANCE GROUP, INC.·4

Feb 26, 4:06 PM ET

Stepnowski Amy 4

4 · HARTFORD INSURANCE GROUP, INC. · Filed Feb 26, 2026

Research Summary

AI-generated summary of this filing

Updated

HIG EVP Amy Stepnowski Receives 13,861-Share Award

What Happened
Amy Stepnowski, Executive Vice President of Hartford Insurance Group (HIG), was granted a derivative award of 13,861 shares on February 24, 2026. The filing reports an acquisition price of $0.00 (derivative award), so there was no cash outlay or immediate sale reported. This is an equity compensation award rather than an open-market purchase or sale.

Key Details

  • Transaction date: 2026-02-24; Form 4 filed 2026-02-26 (appears to be filed on time).
  • Transaction type/code: Award/Grant (A), reported as a derivative.
  • Amount and price: 13,861 shares reported at $0.00 acquisition price (total reported value $0).
  • Vesting/other footnote: Footnote F1 — one-third of the award becomes exercisable on Feb 24, 2027; another one-third on Feb 24, 2028; the final one-third on Feb 24, 2029.
  • Shares owned after transaction: Not specified in the provided Form 4 excerpt.
  • Filing timeliness: Reported within two days of the transaction date (no late filing indicated).

Context
This entry reflects an equity compensation grant (derivative/option award) that vests over three years; it does not represent an immediate purchase or sale. Such awards are common for executive compensation and do not, by themselves, indicate a buying or selling signal. Since this was a grant, there was no immediate cash transaction or disposition reported.

Insider Transaction Report

Form 4
Period: 2026-02-24
Transactions
  • Award

    Stock Option

    [F1]
    2026-02-24+13,86113,861 total
    Exercise: $140.54Exp: 2036-02-24Common Stock (13,861 underlying)
Holdings
  • Common Stock

    31,536.547
  • Stock Option

    [F2]
    Exercise: $69.41Exp: 2032-02-23Common Stock (10,065 underlying)
    10,065
  • Stock Option

    [F3]
    Exercise: $78.28Exp: 2033-02-28Common Stock (26,079 underlying)
    26,079
  • Stock Option

    [F4]
    Exercise: $95.74Exp: 2034-02-27Common Stock (13,582 underlying)
    13,582
  • Stock Option

    [F5]
    Exercise: $116.41Exp: 2035-02-25Common Stock (13,836 underlying)
    13,836
Footnotes (5)
  • [F1]One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
  • [F2]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
  • [F3]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
  • [F4]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date
  • [F5]One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
Signature
Anthony J. Salerno, Jr., Attorney-in-Fact|2026-02-26

Documents

1 file
  • 4
    doc4.xmlPrimary